instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Rebound effect'? | Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver cancer affecting adolescents and young adults wit... | Recovered | ReactionOutcome | CC BY-NC | 32898940 | 18,380,427 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | ATENOLOL, DEXAMETHASONE, ENOXAPARIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, PREDNISONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32910321 | 18,339,887 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | ATENOLOL, DEXAMETHASONE, ENOXAPARIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, PREDNISONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32910321 | 18,339,887 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | AMIODARONE, ATENOLOL, DEXAMETHASONE, ENOXAPARIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, PREDNISONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32910321 | 18,354,382 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | AMIODARONE, ATENOLOL, DEXAMETHASONE, ENOXAPARIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, PREDNISONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32910321 | 18,354,382 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | AMIODARONE, ATENOLOL, DEXAMETHASONE, ENOXAPARIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OXYGEN, PREDNISONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32910321 | 18,340,500 | 2021-06 |
What was the administration route of drug 'DEXAMETHASONE'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the administration route of drug 'TOCILIZUMAB'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the dosage of drug 'ATENOLOL'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | UNKNOWN | DrugDosageText | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the dosage of drug 'ENOXAPARIN'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | UNKNOWN | DrugDosageText | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | UNKNOWN | DrugDosageText | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | UNKNOWN | DrugDosageText | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the dosage of drug 'OXYGEN'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | HIGH-FLOW SUPPLEMENTAL OXYGEN SUPPORT AND OXYGEN WEANING ON DAY 27TH OF HOSPITALIZATION. | DrugDosageText | CC BY | 32910321 | 18,340,500 | 2021-06 |
What was the outcome of reaction 'Condition aggravated'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | Recovering | ReactionOutcome | CC BY | 32910321 | 18,339,887 | 2021-06 |
What was the outcome of reaction 'Infection'? | Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
BACKGROUND
SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested t... | Recovering | ReactionOutcome | CC BY | 32910321 | 18,354,382 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Letermovir for the compassionate therapeutic use of cytomegalovirus infection.
OBJECTIVE
Data on the efficacy, dosing and safety of letermovir for the compassionate therapeutic use of CMV infections are limited.
METHODS
Clinical and virological efficacy of letermovir was assessed in a retrospective single-centre stud... | CORTISONE, LETERMOVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 32914220 | 18,980,760 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Letermovir for the compassionate therapeutic use of cytomegalovirus infection.
OBJECTIVE
Data on the efficacy, dosing and safety of letermovir for the compassionate therapeutic use of CMV infections are limited.
METHODS
Clinical and virological efficacy of letermovir was assessed in a retrospective single-centre stud... | CORTISONE, GANCICLOVIR, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 32914220 | 18,354,465 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.
A 72-year-old man with intractable left shoulder pain due to bone metastasis from cholangiocellular carcinoma was admitted to our hospital. Computed tomography showed an osteobl... | CISPLATIN, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, MORPHINE | DrugsGivenReaction | CC BY-NC-ND | 32921687 | 19,703,168 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.
A 72-year-old man with intractable left shoulder pain due to bone metastasis from cholangiocellular carcinoma was admitted to our hospital. Computed tomography showed an osteobl... | CISPLATIN, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, MORPHINE | DrugsGivenReaction | CC BY-NC-ND | 32921687 | 19,703,168 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.
A 72-year-old man with intractable left shoulder pain due to bone metastasis from cholangiocellular carcinoma was admitted to our hospital. Computed tomography showed an osteobl... | CISPLATIN, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, MORPHINE | DrugsGivenReaction | CC BY-NC-ND | 32921687 | 19,703,168 | 2021-01-15 |
What was the administration route of drug 'MORPHINE'? | Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.
A 72-year-old man with intractable left shoulder pain due to bone metastasis from cholangiocellular carcinoma was admitted to our hospital. Computed tomography showed an osteobl... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32921687 | 19,703,168 | 2021-01-15 |
What was the outcome of reaction 'Somnolence'? | Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.
A 72-year-old man with intractable left shoulder pain due to bone metastasis from cholangiocellular carcinoma was admitted to our hospital. Computed tomography showed an osteobl... | Recovering | ReactionOutcome | CC BY-NC-ND | 32921687 | 19,703,168 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | MINOCYCLINE HYDROCHLORIDE, RUXOLITINIB | DrugsGivenReaction | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paradoxical embolism'. | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 32921692 | 19,814,070 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Right ventricular failure'. | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | MINOCYCLINE HYDROCHLORIDE, RUXOLITINIB | DrugsGivenReaction | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombophlebitis'. | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | MINOCYCLINE HYDROCHLORIDE, RUXOLITINIB | DrugsGivenReaction | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pain'. | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | MINOCYCLINE HYDROCHLORIDE, RUXOLITINIB | DrugsGivenReaction | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
What was the administration route of drug 'RUXOLITINIB'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
What was the outcome of reaction 'Hypoxia'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Recovering | ReactionOutcome | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
What was the outcome of reaction 'Paradoxical embolism'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Recovered | ReactionOutcome | CC BY-NC-ND | 32921692 | 19,814,070 | 2021-01-15 |
What was the outcome of reaction 'Right ventricular failure'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Recovering | ReactionOutcome | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
What was the outcome of reaction 'Thrombophlebitis'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Recovering | ReactionOutcome | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
What was the outcome of reaction 'Vascular pain'? | Pulmonary Embolism and Splenic Infarction after Minocycline Infusion in a Patient with Polycythemia Vera.
A 55-year-old man treated with polycythemia vera visited our hospital, complaining of left abdominal pain and dyspnea. He had received minocycline infusions three weeks earlier for mycoplasma pneumonia. Contrast-en... | Recovering | ReactionOutcome | CC BY-NC-ND | 32921692 | 19,277,792 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the administration route of drug 'PREDNISOLONE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | Oral | DrugAdministrationRoute | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the administration route of drug 'PREDNISONE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | Oral | DrugAdministrationRoute | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the administration route of drug 'RITUXIMAB'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the administration route of drug 'VINCRISTINE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 750 MG/M2 | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'DOXORUBICIN'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 50 MG/M2 | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'PREDNISOLONE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 100 MG (ON DAYS 2 TO 6) | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'PREDNISONE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 100 MG (ON DAYS 2 TO 6) | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'RITUXIMAB'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 375 MG/M2 (DAY 1) | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
What was the dosage of drug 'VINCRISTINE'? | Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
BACKGROUND
Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration... | 1.4 MG/M2 (CAPPED AT 2.0 OR 1.0 MG) ON DAY 2 | DrugDosageText | CC BY | 32944800 | 19,048,567 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | CISPLATIN, DOCETAXEL, FLUOROURACIL, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963156 | 19,040,434 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | CISPLATIN, DOCETAXEL, FLUOROURACIL, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963156 | 19,040,434 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | CEFMENOXIME, HYDROCORTISONE, LINEZOLID, MEROPENEM, MINOCYCLINE HYDROCHLORIDE, NOREPINEPHRINE, POLYMYXIN B, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32963156 | 20,851,605 | 2021-02-01 |
What was the administration route of drug 'NIVOLUMAB'? | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 32963156 | 19,040,434 | 2021-02-01 |
What was the dosage of drug 'HYDROCORTISONE'? | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | UNK,MG/DAY | DrugDosageText | CC BY-NC-ND | 32963156 | 20,851,605 | 2021-02-01 |
What was the dosage of drug 'NIVOLUMAB'? | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | 3 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY-NC-ND | 32963156 | 19,040,434 | 2021-02-01 |
What was the dosage of drug 'PREDNISOLONE'? | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | UNK,MG/DAY | DrugDosageText | CC BY-NC-ND | 32963156 | 20,851,605 | 2021-02-01 |
What was the outcome of reaction 'Neoplasm progression'? | The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy.
We herein report the cytokine expression at different stages for three patients who developed cardiac complications after immune checkpoint inhibitor (ICI) therapy. Case 1 with biopsy-proven myocarditis showed incre... | Fatal | ReactionOutcome | CC BY-NC-ND | 32963156 | 20,851,605 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEVOLEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 17,549,249 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 17,549,249 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jejunal stenosis'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEVOLEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal disorder'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 18,900,762 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small intestinal obstruction'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 18,900,762 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963157 | 17,549,249 | 2021-01-15 |
What was the administration route of drug 'FLUOROURACIL'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the administration route of drug 'GEMCITABINE'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the administration route of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the administration route of drug 'PACLITAXEL'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | 17 COURSES | DrugDosageText | CC BY-NC-ND | 32963157 | 17,549,249 | 2021-01-15 |
What was the dosage of drug 'LEVOLEUCOVORIN CALCIUM'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | UNK (17 COURSES) | DrugDosageText | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the outcome of reaction 'Condition aggravated'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Fatal | ReactionOutcome | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the outcome of reaction 'Disease progression'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Fatal | ReactionOutcome | CC BY-NC-ND | 32963157 | 17,549,249 | 2021-01-15 |
What was the outcome of reaction 'Jejunal stenosis'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Recovering | ReactionOutcome | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the outcome of reaction 'Neutropenia'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963157 | 19,122,828 | 2021-01-15 |
What was the outcome of reaction 'Small intestinal obstruction'? | Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.
A 65-year-old man diagnosed with locally advanced pancreatic cancer underwent distal pancreatectomy and combined portal vein resection. One month after surgery, contrast-enhanced magnetic resonance imaging... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963157 | 18,900,762 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
We herein describe an 82-year-old patient who presented with proteinuria and systemic edema. He was diagnosed with minimal change disease (MCD) and was found to have stage III pancreatic cancer. He could not undergo surgical resection d... | DEXAMETHASONE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 32963158 | 18,354,536 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriospasm coronary'. | Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.
A 19-year-old-man was admitted to our hospital with intermittent chest pain. The day before admission, he had been diagnosed with enteritis and prescribed clarithromycin. He had experienced severe chest pain three t... | CLARITHROMYCIN | DrugsGivenReaction | CC BY-NC-ND | 32963159 | 18,431,710 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Kounis syndrome'. | Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.
A 19-year-old-man was admitted to our hospital with intermittent chest pain. The day before admission, he had been diagnosed with enteritis and prescribed clarithromycin. He had experienced severe chest pain three t... | CLARITHROMYCIN | DrugsGivenReaction | CC BY-NC-ND | 32963159 | 18,386,094 | 2021-01-15 |
What was the administration route of drug 'CLARITHROMYCIN'? | Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.
A 19-year-old-man was admitted to our hospital with intermittent chest pain. The day before admission, he had been diagnosed with enteritis and prescribed clarithromycin. He had experienced severe chest pain three t... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32963159 | 18,386,094 | 2021-01-15 |
What was the outcome of reaction 'Arteriospasm coronary'? | Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.
A 19-year-old-man was admitted to our hospital with intermittent chest pain. The day before admission, he had been diagnosed with enteritis and prescribed clarithromycin. He had experienced severe chest pain three t... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963159 | 18,431,710 | 2021-01-15 |
What was the outcome of reaction 'Kounis syndrome'? | Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.
A 19-year-old-man was admitted to our hospital with intermittent chest pain. The day before admission, he had been diagnosed with enteritis and prescribed clarithromycin. He had experienced severe chest pain three t... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963159 | 18,386,094 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B reactivation'. | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, MELPHALAN, METHOTREXATE SODIUM, PREDNISOLONE SODIUM SUCCINATE, PROCARBAZINE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, MELPHALAN, METHOTREXATE SODIUM, PREDNISOLONE SODIUM SUCCINATE, PROCARBAZINE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
What was the dosage of drug 'MELPHALAN'? | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | UNK UNK, CYCLIC (1 COURSE OF R?LEED THERAPY) | DrugDosageText | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | UNK UNK, CYCLIC (2 COURSES OF R?MPV THERAPY) | DrugDosageText | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
What was the dosage of drug 'PROCARBAZINE'? | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | UNK UNK, CYCLIC (2 COURSES OF R?MPV THERAPY) | DrugDosageText | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
What was the outcome of reaction 'Hepatitis B reactivation'? | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
What was the outcome of reaction 'Hepatitis'? | Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
A 54-year-old woman underwent chemotherapy including rituximab and autologous peripheral blood stem cell transplantation (auto-PBSCT) for diffuse large B-... | Recovered | ReactionOutcome | CC BY-NC-ND | 32963163 | 18,381,225 | 2021-02-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | DALBAVANCIN, DAPTOMYCIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY | 32965641 | 19,165,851 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | AMOXICILLIN, LINEZOLID, MOXIFLOXACIN, RIFAMPIN | DrugsGivenReaction | CC BY | 32965641 | 20,453,567 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | AMOXICILLIN, LINEZOLID, MOXIFLOXACIN, RIFAMPIN | DrugsGivenReaction | CC BY | 32965641 | 20,453,567 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersensitivity'. | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | AMOXICILLIN, LINEZOLID, MOXIFLOXACIN, RIFAMPIN | DrugsGivenReaction | CC BY | 32965641 | 20,453,567 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | AMOXICILLIN, LINEZOLID, MOXIFLOXACIN, RIFAMPIN | DrugsGivenReaction | CC BY | 32965641 | 20,453,567 | 2021-02 |
What was the administration route of drug 'MOXIFLOXACIN'? | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | Oral | DrugAdministrationRoute | CC BY | 32965641 | 20,453,567 | 2021-02 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 32965641 | 19,165,851 | 2021-02 |
What was the administration route of drug 'RIFAMPIN'? | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | Oral | DrugAdministrationRoute | CC BY | 32965641 | 20,453,567 | 2021-02 |
What was the dosage of drug 'DAPTOMYCIN'? | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | 10 MG/KG | DrugDosageText | CC BY | 32965641 | 19,165,851 | 2021-02 |
What was the outcome of reaction 'Cerebrovascular accident'? | Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1, Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, trans... | Fatal | ReactionOutcome | CC BY | 32965641 | 19,165,851 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastroenteritis radiation'. | Acute Ileal Perforation Caused by Radiation Enteritis After Restoration.
Few radiation-induced bowel perforations have been reported to date. Furthermore, perforation after ileal restoration in asymptomatic patients is rare. We report the case of a 61-year-old man who was administered preoperative chemoradiotherapy for... | CAPECITABINE | DrugsGivenReaction | CC BY-NC | 32972095 | 19,962,131 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileal perforation'. | Acute Ileal Perforation Caused by Radiation Enteritis After Restoration.
Few radiation-induced bowel perforations have been reported to date. Furthermore, perforation after ileal restoration in asymptomatic patients is rare. We report the case of a 61-year-old man who was administered preoperative chemoradiotherapy for... | CAPECITABINE | DrugsGivenReaction | CC BY-NC | 32972095 | 19,962,131 | 2021-07 |
What was the dosage of drug 'CAPECITABINE'? | Acute Ileal Perforation Caused by Radiation Enteritis After Restoration.
Few radiation-induced bowel perforations have been reported to date. Furthermore, perforation after ileal restoration in asymptomatic patients is rare. We report the case of a 61-year-old man who was administered preoperative chemoradiotherapy for... | CUMULATIVE DOSE OF 5,040 CGY, DIVIDED INTO 28 CYCLES | DrugDosageText | CC BY-NC | 32972095 | 19,962,131 | 2021-07 |
What was the outcome of reaction 'Gastroenteritis radiation'? | Acute Ileal Perforation Caused by Radiation Enteritis After Restoration.
Few radiation-induced bowel perforations have been reported to date. Furthermore, perforation after ileal restoration in asymptomatic patients is rare. We report the case of a 61-year-old man who was administered preoperative chemoradiotherapy for... | Recovered | ReactionOutcome | CC BY-NC | 32972095 | 19,962,131 | 2021-07 |
What was the outcome of reaction 'Ileal perforation'? | Acute Ileal Perforation Caused by Radiation Enteritis After Restoration.
Few radiation-induced bowel perforations have been reported to date. Furthermore, perforation after ileal restoration in asymptomatic patients is rare. We report the case of a 61-year-old man who was administered preoperative chemoradiotherapy for... | Recovered | ReactionOutcome | CC BY-NC | 32972095 | 19,962,131 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
To investigate safety and efficacy of MMF in patients with severe or MTX-refractory juvenile localized scleroderma.
Consecutive juvenile localized scleroderma patients undergoing systemic treatment were included in a retrospective longi... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32978631 | 18,385,849 | 2021-03-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
To investigate safety and efficacy of MMF in patients with severe or MTX-refractory juvenile localized scleroderma.
Consecutive juvenile localized scleroderma patients undergoing systemic treatment were included in a retrospective longi... | METHOTREXATE | DrugsGivenReaction | CC BY-NC | 32978631 | 18,385,849 | 2021-03-02 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.